Implications of Two-component Systems EnvZ/OmpR and BaeS/BaeR in in Vitro Temocillin Resistance in Escherichia Coli

Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli Patricia Pérez-Palacios 1,2 †, José Luis Rodríguez-Ochoa 1,2 †, Ana Velázquez-Escudero 1 , Jesús Rodríguez-Baño 1,2,3,4 , José Manuel Rodríguez-Martínez 2,4,5 , Álvaro Pascual 1,2,4,5 ‡ and Fernando Docobo-Pérez 2,4,5 *‡ 1 Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain; 2 Instituto de Biomedicina de Sevilla IBIS, Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Sevilla, Spain; 3 Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain; 4 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; 5 Departamento de Microbiología, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain *Corresponding author. E-mail: [email protected] †These authors contributed equally. ‡These authors contributed equally. Received 31 October 2023; accepted 10 January 2024 Background: BaeS/BaeR is a two-component system of Escherichia coli that controls the expression of porins and efflux pumps. Its role in beta-lactam resistance is limited. Objectives: To study the role of baeS/baeR two-component system in temocillin resistance in E. coli. Methods: E. coli strain BW25113 and single-gene deletion mutants related to two-component systems were collected from the KEIO collection. Double-gen deletion mutants were generated. Temocillin-resistant mutant frequencies were determined at 32 mg/L. E. coli BW25113 mutants were selected by selective pressure from serial passages. Biological costs were analysed by growth curves. Genomes of the generated mutants were sequenced. The expression level of the mdtA, mdtB, mdtC, acrD and tolC in the ΔbaeS mutant was determined by RT–PCR (with/without temocillin exposure). Results: The frequency of temocillin mutants ranged from 2.12 × 10 −8 to 4.51 × 10 −8 in single-porin mutants. No mutants were recovered from E. coli BW25113 (>10 −9 ). Selection of temocillin-resistant variants by serial passage yielded mutants up to 128 mg/L. Mutations were found in the baeS gene. Temocillin MICs ranged from 4 to 32 mg/L (highest MICs for ΔbaeS and ΔompR). The efflux pumps mdtA, mdtB, mdtC and acrD pumps were overexpressed 3–10-fold in the presence of temocillin in ΔbaeS compared to control. Conclusions: Mutations in the sensor histidine kinase, baeS, may be involved in temocillin resistance through the expression of the efflux pumps mdtABC and acrD. In addition, the low mutation rate may be a good predictor of temocillin activity. © The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction Antimicrobial resistance is one of the biggest threats facing public health in infectious diseases. In recent years, the increase in multidrug-resistant Enterobacterales has been a challenge in patient management due to the reduction in therapeutic options. Despite the importance in promoting research and development of new antibiotics, investment from the pharmaceutical industry and biotech companies is declining and, in the last decade, the FDA has approved only 17 new systemic antibiotics. 1,2 Owing to the lack of new antibiotic molecules, ‘old antibiotics’ such as colistin and some aminoglycosides have been rescued to treat infections caused by to multidrug-resistant bacteria. 3 In this context, the use of temocillin, a semi-synthetic 6-α-methoxy derivative of ticarcillin marketed in the 1980s with a spectrum of action against Enterobacterales and currently available for use in countries such as Belgium, France, Germany, Luxembourg and the UK has been recovered. 4 Resistance to β-lactams in Enterobacterales is mainly mediated by the production of ESBL, AmpC and carbapenemases. 5 The temocillin stability against ESBL- and AmpC-type β-lactamases 641 J Antimicrob Chemother 2024; 79: 641–647 https://doi.org/10.1093/jac/dkae021 Advance Access publication 2 February 2024 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 and some carbapenemases such as KPC-type, has made it an alternative to antibiotics of last resort such as carbapenems, avoiding its overuse. 6 However, although the main β-lactam resistance mechanisms are mediated by enzyme production, changes in membrane permeability also play an important role through alterations in the expression of outer membrane porins (Omps) and/or efflux pumps, causing resistance in Enterobacterales. 7,8 However, these types of study are scarce in temocillin, whose resistance mechanisms remain largely unknown. Porins and efflux pumps are channels located in the plasma membrane of Gram-negative bacteria required for the exchange of small molecules and nutrients, whose expression is regulated by changes in external stress conditions. 9 Some of these are tightly regulated by two-component systems, consisting of a membranebound histidine kinase that senses changes in the environment and sends a response to a regulator that modulates the differential expression of the genes involved. 10 The envZ/ompR system is a twocomponent system in which envZ has the role of a histidine kinase sensor and ompR acts as a regulator of two porins, ompC and ompF. There are other porins, including ompA, ompX and ompW, but although their regulation is also modulated by environmental conditions, they appear to be independent of the control of the envZ/ompR system. 11 While ompA plays an important role in maintaining the membrane integrity, 12 ompW and ompX have been implicated in different responses to external stresses, including iron homeostasis. 13 In addition to the envZ/ompR, another twocomponent system, baeS/baeR, has also been implicated in drug resistance in E. coli. 14 The sensor kinase BaeS and the response regulator BaeR modulate the expression of inner efflux pumps mdtABC and acrD, 15 which, in conjunction with the outer membrane efflux pump tolC, allow the efflux of a variety of compounds from the outer membrane. 16 Moreover, recent studies suggest that single point mutations in the BaeS increase temocillin resistance in Enterobacter cloacae complex, although more studies are needed to confirm this in other species of Enterobacterales. 17 Therefore, the objective of this study was to determine the role of porins and efflux pumps in resistance mechanisms to temocillin in E. coli under the control of the two-component systems envZ/ompR and baeS/baeR. Materials Bacterial strains The wild-type E. coli BW25113 strain and single-gene deletion mutants related to two-component systems that express porins envZ/ ompR (ΔenvZ, ΔompR, ΔompA, ΔompC, ΔompF, ΔompW, ΔomprX) and efflux pumps baeS/baeR (ΔbaeS, ΔbaeR, ΔtolC, ΔacrD, ΔmdtA, ΔmdtB and ΔmdtC), were collected from the KEIO collection. 18 The double deletion mutants, ΔompR-ΔompF, ΔompR-ΔompW, ΔompR-ΔompX, ΔompR-ΔompA, ΔompC-ΔompR, ΔompC-ΔompF, ΔompW-ΔompC, ΔompX-ΔompC, ΔompA-ΔompC, ΔompF-ΔompX and ΔompX-ΔompW, were generated by phage P1vir transduction (Coli Genetic Stock Center, Yale University) from the previously selected strains, as described. 19 Temocillin mutant frequency determination Temocillin-resistant mutant frequencies were evaluated for the wild-type E. coli BW25133 and the single-gene deletion porin mutants (ΔompR, ΔompF, ΔompC, ΔompA, ΔompX and ΔompW). Mutant frequencies were determined in quadruplicate as previously described. 20 Briefly, bacterial cultures were plated on drug-free MHA and MHA plates supplemented with 32 mg/L of temocillin (Eumedica, Belgium), colonies were enumerated after 24 h incubation at 37°C and mutant frequencies were calculated as the ratio of temocillin-resistant mutant cfu to total cfu. In vitro selection of temocillin resistance via serial passages and bacterial fitness Selection of resistance to temocillin in E. coli BW25113 was performed by serial passage in 2-fold temocillin concentration in each subculture, in a range of 2–128 mg/L. Serial passage experiments were performed on MHA plates supplemented with each temocillin concentration. The fitness cost was measured by the growth time (doubling time in h) in E. coli BW25113, the mutants recovered at each temocillin concentration above 16 mg/L and the mutants obtained in temocillin frequency assay. Growth curves were generated in 96-well plates at 37°C and read every hour at OD 600 (Infinite Nano 200 Pro; TECAN, Switzerland). Analyses were performed by fitting a non-parametric form (smoothing factor 0.55) the experimental growth curves using QurvE v.1.1 and the means values of each mutant were compared to control E. coli BW25113 by Student’s t-test (P ± 0.05). 21 Whole-genome sequencing The bacterial genomes of the mutants recovered from the serial passage study at concentrations >16 mg/L temocillin and the mutants obtained from the mutant frequency assay at 32 mg/L temocillin were sequenced using the MiSeq platform system (Illumina, San Diego, CA, USA). DNA extractions were performed with automatic system MagCore HF16 Plus (RCBBioscience, New Taipei City, Taiwan). Sample library was prepared with the Nextera XT DNA library preparation kit (Illumina, CA, USA) and DNA sequencing was carried out with the MiSeq Reagent Kit V3 (600 cycles) and the Illumina MiSeq sequencer (2 × 300 paired-end reads). The reads were quality filtered and de novo assembling of raw reads into contigs using were performed using CLC Genomic Workbench v.9.1 (Qiagen, Hilden, Germany). Mutations were called using the Breseq variant report v.0.35 via Galaxy/Pasteur (https://galaxy.pasteur.fr) using annotated genome of E. coli BW25113 as reference (NZ_CP009273.1). 22 Antimicrobial susceptibility testing Antimicrobial susceptibility testing to temocillin (Eumedica, Belgium), ertapenem (Sigma Aldrich, USA), tobramycin (Sigma Aldrich), fosfomycin (Santa Cruz Biotechnology, USA) and ciprofloxacin (Sigma Aldrich, USA) was determined by microdilution assay according to ISO 20776-1:2019 (European Committee for Standardization 2006). Microdilution was performed in 96-well plates containing concentration between 128 and 0.06 mg/L in MHB medium for temocillin, tobramycin and fosfomycin and between 16 and 0.002 mg/L for ertapenem and ciprofloxacin. The MIC of each antibiotic was selected by the mean of three determinations considering as the lowest concentration showing no visible growth. To study possible cross-resistance for E. coli Pérez-Palacios et al. 642 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 BW25113, ΔbaeS mutant, mutants obtained after sequential passages and single-gene deletion porin mutants, disc diffusion was performed for ampicillin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, cefepime, aztreonam, ertapenem, imipenem and meropenem in accordance with EUCAST guidelines. Also, heteroresistance phenotype to temocillin, done by gradient strip assays following the manufacturer’s instructions, to E. coli ATCC 25922 was used as a control strain. Real-time quantitative RT–PCR (RT–qPCR) The genes encoding pumps regulated by the two-component baeS/baeR system (mdtA, mdtB, mdtC and acrD) and the notdirectly related genes tolC and acrA, were selected to verify the expression level of these. Expression levels were measured by RT–qPCR (LifeCycler, Roche, Switzerland) in the ΔbaeS mutant using E. coli BW25113 as control, with or without exposure to temocillin concentrations of 16 and 2 mg/L, respectively. Total RNA was extracted using QIAcubesQiagen (Venlo, the Netherlands), following the manufacturer’s instructions. cDNA was synthesized from total RNA samples using transcriptor first strand cDNA synthesis kit (Roche, Switzerland). Real-time PCR was performed in the LightCycler 480 Instrument II (Roche, Switzerland) with specific primers (Supplementary Table S1, available as Supplementary data at JAC Online). gyrB was chosen as a housekeeping gene. The relative expression levels of each gene were calculated using the 2 −△△ Ct method. Experiments were performed in triplicate. Results Temocillin-resistant mutant characterization The temocillin mutant frequencies for the isogenic collection are shown in Table 1. Inactivation of porin genes resulted in the selection of mutants at 32 mg/L in ΔompR, ΔompF, ΔompC, ΔompX, ΔompW (ΔompR-32, ΔompF-32, ΔompC-32, ΔompX-32, ΔompW-32). No ΔompA-derived mutants were obtained. Temocillin mutant frequencies in these isolates ranged from 2.12 × 10 −8 to 4.51 × 10 −8 (Table 1). Mutants recovered from mutant frequencies assay showed a MIC to temocillin between 64– 128 mg/L (Table 1). However, when one-step mutant frequency assay at a concentration of 32 mg/L of temocillin was performed in E. coli BW251113, no mutants were recovered. After serial passages, E. coli BW25113 was able to grow in duplicate at each temocillin concentrations of 4, 8, 16, 32, 64 and 128 mg/L. All mutants recovered from the serial passage assay showed a 2– 32-fold increase MIC to temocillin over control E. coli BW25113 (Table 1). Regarding fitness cost analyses, mutants recovered at 16, 32, 64 and 128 mg/L significantly increased their doubling time between 1.5- and 2.9-fold longer than E. coli BW25113, with mutant BW25113-64 and the BW25113-128 showing the longest doubling time. The mutants obtained in the temocillin frequency assay showed no significant difference in their doubling time compared to the control E. coli BW25113 (Table 1). Mutations relative to E. coli BW25113 were compared using Breseq mutation prediction pipeline. Mutants generated at 32, 64 and 128 mg/L of temocillin, in the serial passages assay, contained a significant number of reads carrying the mutation Q163E (CAG→GAG) (P < 0.001) in the histidine kinase sensor baeS at position 2 156 843 in the chromosome, whereas this mutation was not found in the mutant generated at 16 mg/L (Table 1). Analysis of the mutations in the isolates obtained from the mutant frequency assay, also identified point mutations in baeS, specifically S167I (AGC→ATC) in the ompR and ompW mutants, V270G (GTG→GGG) in the ompC mutant, D156N (GAT→AAT) in the ompF mutant. In the ompX mutant, a 6 bp deletion was found between positions 2156469 and 2156476 (Table 1). Antimicrobial susceptibility The analysis of a E. coli BW25113 mutant isogenic collection allowed to us determine the impact of multiple porins and efflux pumps in temocillin resistance. MICs to temocillin ranged from 1 to 32 mg/L, with the highest MICs ΔbaeS (MIC 32 mg/L) and ΔompR (MIC 16 mg/L) mutants with an increase of 8- and 4-fold increase, respectively, compared to E. coli BW25113 (MIC of 4 mg/L) (Table 2). The lowest MIC was recorded in ΔtolC (MIC of 1 mg/L) with a 4-fold decrease in temocillin concentration compared to E. coli BW25113. Other antibiotics whose resistance is associated with changes in membrane permeability with loss of porins (ertapenem), efflux pumps (ciprofloxacin and tobramycin) or defects in the synthesis of transporters (fosfomycin), were also tested in the isogenic collection. For ertapenem, the MICs ranged from 0.003 to 0.5 mg/L. Of the single-gene deletion mutants, the loss of the ompF and ompR genes resulted in a 4- and 64-fold increase, in MIC, respectively. MICs to ciprofloxacin, fosfomycin and tobramycin in these mutants ranged from 0.001–0.125 mg/L, 1–4 and 0.25–2 mg/L, respectively, in these mutants. The tolC mutant showed a 2-fold decreased in MICs to these antimicrobials compared to E. coli BW25113. The temocillin MICs of the double-porin mutants ranged from 4 to 16 mg/L. Mutants with deletions in ompR reached an MIC at temocillin of 16 mg/L, with no differences with respect to the single ompR mutant. The double loss of the ompC and ompF porins did not increase the MIC at temocillin with respect to the E. coli BW25113 control. With respect to other antibiotics, double-porin mutants (except double-gene mutants of ompA or ompW) increased their MIC to ertapenem 4- to 64-fold compared to the control. There were no significant MIC changes to ciprofloxacin or tobramycin in these double-gene mutants. With respect to cross-resistance, a reduction in the size of ampicillin inhibition halo (3–4 mm, changing clinical category from susceptible to resistance) was observed in the mutants obtained with serial passages and a reduction in aztreonam inhibition halo (4 mm with no changes in clinical category) was observed for the BW-64 and BW-128 mutants. No cross-resistance was found for the rest of the β-lactams studied (Supplementary Table S2). Regarding heteroresistance phenotype, colonies within the ampicillin inhibition halo were observed in the strains studied, including for the control E. coli BW-25113 (Supplementary Table S2). Colonies or double inhibition halos were also observed near the ellipse of the temocillin gradient strips for all the strains studied (Supplementary Figure S1). Efflux pumps expression The genes encoding efflux pumps, regulated by the twocomponent baeS/baeR system in addition to tolC and acrA, Temocillin resistance in E. coli 643 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 Table 1 . Temocillin MIC (mg/L), position and mutations found in baeS gene in E. coli BW25113 and isogenic collection generated by serial passage in increasing temocillin concentration and mutant obtained from porin deficiency isolates in the mutant frequency assay (32 mg/L), temocillin mutant frequency (percentage of reads) and fitness cost measured by duplication time (h). Bold indicates amino acid change and position Strain name MIC (mg/L) Information of mutations in baeS gene Position Codon change Frequency P value Temocillin mutant frequency (mean + SD) Duplication time (h) E. coli BW25113 4 — — — — >10 −9 0.67 ± 0.15 BW25113-16 16 ND ND ND ND — 1.03 ± 0.22 a BW25113-32 32 2 156 843 Q163E (CAG→GAG) 96% 0.053 — 1.48 ± 0.93 a BW25113-64 64 2 156 843 Q163E (CAG→GAG) 100% 0.001 — 1.94 ± 1.29 a BW25113-128 128 2 156 843 Q163E (CAG→GAG) 98% 0.034 — 1.54 ± 0.92 a ΔompR-32 64 2 156 856 S167I (AGC→ATC) 100% 0.001 4.51 × 10 −8 ± 2.06 × 10 −8 0.76 ± 0.18 ΔompC-32 64 2 157 165 V270G (GTG→GGG) 100% 0.001 2.74 × 10 −8 ± 1.07 × 10 −8 0.72 ± 0.17 ΔompF-32 128 2 156 822 D156N (GAT→AAT) 100% 0.001 3.77 × 10 −8 ± 2.76 × 10 −8 0.70 ± 0.19 ΔompX-32 64 2,156,469-2,156,476 Δ6 bp 100% 0.001 2.94 × 10 −8 ± 1.66 × 10 −8 0.68 ± 0.17 ΔompW-32 64 2 156 856 S167I (AGC→ATC) 100% 0.001 2.12 × 10 −8 ± 1.44 × 10 −8 0.65 ± 0.14 ND, not detected. a P ≤ 0.05. Table 2. Antimicrobial susceptibility (MIC, mg/L) of E. coli BW25113 mutant isogenic collection Strain name MIC (mg/L) TEM ERT CIP FOT TOB ATCC25922 16 0.008 0.008 1 0.5 BW25113 4 0.008 0.008 1 0.5 ΔenvZ 8 0.004 0.008 1 1 ΔompR 16 0.5 0.016 4 1 ΔompA 8 0.004 0.008 2 1 ΔompC 4 0.004 0.008 2 0.5 ΔompF 16 0.06 0.016 2 2 ΔompX 8 0.016 0.008 1 1 ΔompW 8 0.004 0.002 1 2 ΔbaeS 32 0.006 0.008 1 1 ΔbaeR 8 0.004 0.008 4 2 ΔacrD 8 0.004 0.125 1 1 ΔmdtA 8 0.016 0.125 2 0.5 ΔmdtB 8 0.016 0.004 2 0.5 ΔmdtC 8 0.016 0.004 1 0.5 ΔtolC 1 0.004 0.002 1 0.25 ΔompR-ΔompC 16 0.25 0.006 8 0.5 ΔompR-ΔompF 16 0.5 0.016 8 0.5 ΔompR-ΔompA 8 0.125 0.016 2 0.25 ΔompR-ΔompW 16 0.125 0.016 4 0.5 ΔompC-ΔompF 8 0.5 0.016 8 0.5 ΔompC-ΔompA 4 0.016 0.006 2 0.25 ΔompC-ΔompW 4 0.06 0.006 2 0.5 ΔompC-ΔompX 4 0.006 0.006 1 0.5 ΔompF-ΔompX 16 0.03 0.03 2 0.5 ΔompF-ΔompW 8 0.03 0.03 32 1 ΔompA-ΔompX 8 0.016 0.016 4 0.5 ΔompA-ΔompW 4 0.016 0.016 1 1 ΔompW-ΔompX 4 0.016 0.016 2 1 Pérez-Palacios et al. 644 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 were measure in response to temocillin in the ΔbaeS mutant compared to the control E. coli BW25113. Without temocillin exposure, the expression of the studied efflux pumps did not change in the ΔbaeS mutant compared to the control E. coli BW25113. When single mutant ΔbaeS and E. coli BW25113 were exposed to 1/2xMIC of temocillin, mdtA, mdtC and acrD genes were overexpressed by 7-, 4- and 10-fold, respectively, in ΔbaeS compared to the expression of these efflux pumps in the control E. coli BW25113. The expression levels of tolC and acrA, did not change on exposure to temocillin (Figure 1). Discussion This work provides insight into the resistance mechanisms to temocillin in E. coli through the involvement of the twocomponent systems envZ/ompR and baeS/baeR, finding that mutations or deletions in the sensor histidine kinase BaeS lead to an increase in MIC to temocillin, mediated by overexpression in the efflux pumps acrD, mdtABC. Temocillin is a recently rescued forgotten antibiotic due to its resistance to hydrolysis by Ambler class A and C β-lactamases. 6 However, the molecular basis of resistance to temocillin remains largely unknown and although alterations in membrane permeability and the enzymatic barrier are known to contribute to antibiotic resistance in E. coli, 12,23 there are few studies elucidating it with temocillin. It is proposed that the frequency of selection of mutants in vitro to temocillin is low, as is the selection of resistant mutants detected in vivo. 24 In terms of the frequency of spontaneous mutant appearance, the frequency of appearance of single-porin mutants was 10 −8 , in contrast to the results obtained with E. coli BW25113 where no temocillin-resistant mutant was recovered. These data agree with other studies where the frequency of occurrence of temocillin mutants reached 10 −8 . 25 However, mutants were recovered from E. coli BW25113 during serial passage. In all these recovered mutants, the MIC to temocillin was increased between 2- and 32-fold, compared to control E. coli BW25113. Analysis of the relative mutations in mutants obtained at 32, 64 and 128 mg/L of temocillin, showed various changes in the BaeS histidine kinase sensor as well as in the porin mutants recovered from the mutant frequency assay. In this work, the doubling time of the mutants recovered in the serial passaging assay with temocillin was slightly longer than that of the control E. coli BW25113. It is known that strains with mutations conferring antibiotic resistance often have a lower growth rate, but these mutations may confer a survival advantage that selects for the resistant population. 26 Although temocillin resistance was not reversed and the MIC to temocillin remained stable in the mutants, it is unclear how this fitness cost could impact clinical isolates or if this biological cost could be compensated for by other mutations. The regulation of the membrane permeability through reducing uptake by downregulating the expression of porins, or by increasing the efflux of compounds by overexpressing efflux pumps, is mediated by two-component systems. 27 The twocomponent systems, Envz/OmpR and BaeS/BaeR, regulate membrane permeability via porins and efflux pumps, respectively. In this study, the MIC to temocillin was studied in single mutants of several porins in an isogenic collection. Although it was originally thought that resistance to temocillin could be due to a reduced entry of the molecule into the cell through the porins of the outer membranes, 28 single mutants of ΔompC, ΔompF, ΔompA, ΔompX and ΔompW did not show a significant increase in their MIC to temocillin compared to the control E. coli BW25113. An increase in 4xCMI was only observed for the single -mutant ΔompR, the main regulator of OmpC and OmpF, porins for which changes in their expression have been described to confer a decreased susceptibility to some beta-lactams such as ertapenem. 29 Indeed, loss of the ompF and ompR genes resulted in 4- and 64-fold increases in MIC to ertapenem, respectively. Whereas there are studies linking resistance to other betalactams, such as ceftriaxone, in S. enterica, mediated by OmpW and OmpX-like porins, 30 no increase in MIC to temocillin was observed for the loss of these in our study. Similarly, no changes in MICs to temocillin were observed in the double-porin mutants, which obtained the same MIC values as their single mutants. The BaeS/BaeR two-component system has also been linked to antimicrobial resistance in E. coli. 31 Moreover, it has been described that overproduction of BaeR can also cause novobiocin resistance through overexpression of the drug efflux system mdtABC. 32 In this work, mutation and deletions cause overexpression of the efflux pump mdtABC, and especially of acrD. Moreover, ΔbaeS mutant increased its MIC to temocillin up to 8-fold in compared to the control. In addition to novobiocin resistance, increased erythromycin resistance has also been described by gain-of-function mutations in baeS that constitutively activate the baeSR two-component regulatory system to increase expression of the efflux pump mdtABC. 33 Although in Enterobacterales both baeS and baeR have been implicated in resistance to ciprofloxacin through activation of the histidine kinase sensor 34 and to ceftriaxone through loss of baeR, 30 the involvement of the baeS/baeR two-component system in antibiotic resistance remains unclear. Recently, Guérin et al. showed that temocillin resistance in the Enterobacter asburiae can result from a single BaeS alteration, probably resulting in the Figure 1. Fold change expression of the efflux pump components tolC, mdtA, mdtB, mdtC, acrD and acrA in the ΔbaeS compared to E. coli BW25113 with and without temocillin exposure. Temocillin resistance in E. coli 645 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 permanent phosphorylation of BaeR and leading to AcrD overexpression and temocillin resistance through enhanced active efflux. 17 However, because of the presence of polymorphisms present in baeS from different Enterobacterales species and even within the same species, it is not possible to compare these point-single mutations. This work has certain limitations. This study used the KEIO collection, which is derived from a non-uropathogenic intestinal strain of E. coli K12. It is unclear how the selected mutations may affect other E. coli strains from different sources with varying responses to factors such as nutrient intake and cellular homeostasis, which are involved in the regulation of resistance mechanisms such as porins and efflux pumps. Also, this study was performed entirely under in vitro conditions and it is unknown what effects of two-component systems may affect temocillin resistance in vivo. Further studies are needed to clarify the in vivo implications of this temocillin resistance. In conclusion, alterations in E. coli membrane porins may not be involved in temocillin resistance. However, this work has shown that mutations in the histidine kinase sensor BaeS can alter the expression of plasma membrane efflux pumps in E. coli by overexpressing the efflux pumps mdtABC and acrD contributing to temocillin resistance. Although this resistance has some biological cost in terms of growth rate, it does not appear to contribute significantly to the development of the mutants. In addition, the low rate of mutant emergence may be a good predictor of temocillin activity. Acknowledgements Temocillin was kindly provided by Eumedica Pharmaceuticals. Funding This study was funded by a grant from ‘Proyectos I + D + i Agentes del Sistema Andaluz del Conocimiento (PAIDI 2020), Junta de Andalucía, P20-00985’. Patricia Pérez-Palacios is supported by a contract ‘Modalidad contrato postdoctoral especialista’ from the Consejería de Salud y Familias, Junta de Andalucía (RH-0136-2020). The funders had no role in the design, collection of data, analysis and writing of the manuscript or the decision to publish. This study was presented in part at ECCMID 2023 (Abstract number 02561). Transparency declarations None to declare. Supplementary data Figure S1 and Tables S1 and S2 are available as Supplementary data at JAC Online. References 1Outterson K, Rex JH. Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization. Transl Res 2020; 220: 182–90. https://doi.org/10.1016/j.trsl.2020. 02.006 2Chahine EB, Dougherty JA, Thornby KA et al. Antibiotic approvals in the last decade: are we keeping up with resistance? Ann Pharmacother 2022; 56: 441–62. https://doi.org/10.1177/10600280211031390 3Peri AM, Doi Y, Potoski BA et al. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn Microbiol Infect Dis 2019; 94: 413–25. https://doi.org/10.1016/j.diagmicrobio.2019.01.020 4Balakrishnan I, Koumaki V, Tsakris A. Temocillin: is this the right momentum for its global use? Future Microbiol 2019; 14: 81–3. https://doi. org/10.2217/fmb-2018-0316 5Palzkill T. Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC β-lactamases. Front Mol Biosci 2018; 5: 16. https://doi.org/10.3389/ fmolb.2018.00016 6Livermore DM, Tulkens PM. Temocillin revived. J Antimicrob Chemother 2009; 63: 243–5. https://doi.org/10.1093/jac/dkn511 7Blair JM, Webber MA, Baylay AJ et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015; 13: 42–51. https://doi.org/10. 1038/nrmicro3380 8Abushaheen MA, Muzaheed, Fatani AJ et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 2020; 66: 100971. https://doi.org/10.1016/j.disamonth.2020.100971 9Masi M, Winterhalter M, Pagès JM. Outer membrane porins. Subcell Biochem 2019; 92: 79–123. https://doi.org/10.1007/978-3-030-18768-2_4 10 Lingzhi L, Haojie G, Dan G et al. The role of two-component regulatory system in β-lactam antibiotics resistance. Microbiol Res 2018; 215: 126–9. https://doi.org/10.1016/j.micres.2018.07.005 11 Nakashima K, Horikoshi K, Mizuno T. Effect of hydrostatic pressure on the synthesis of outer membrane proteins in Escherichia coli. Biosci Biotechnol Biochem 1995; 59: 130–2. https://doi.org/10.1271/bbb.59.130 12 Choi U, Lee CR. Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in Escherichia coli. Front Microbiol 2019; 10: 953. https://doi.org/10.3389/fmicb.2019.00953 13 Lin X, Wu L, Li H et al. Downregulation of Tsx and OmpW and upregulation of OmpX are required for iron homeostasis in Escherichia coli. J Proteome Res 2008; 7: 1235–43. https://doi.org/10.1021/pr7005928 14 Hirakawa H, Nishino K, Hirata T et al. Comprehensive studies of drug resistance mediated by overexpression of response regulators of twocomponent signal transduction systems in Escherichia coli. J Bacteriol 2003; 185: 1851–6. https://doi.org/10.1128/JB.185.6.1851-1856.2003 15 Leblanc SK, Oates CW, Raivio TL. Characterization of the induction and cellular role of the BaeSR two-component envelope stress response of Escherichia coli. J Bacteriol 2011; 193: 3367–75. https://doi.org/10.1128/ JB.01534-10 16 Rosner JL, Martin RG. Reduction of cellular stress by TolC-dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants. J Bacteriol 2013; 195: 1042–50. https://doi.org/ 10.1128/JB.01996-12 17 Guérin F, Gravey F, Reissier S et al. Temocillin resistance in the Enterobacter cloacae complex is conferred by a single point mutation in BaeS, leading to overexpression of the AcrD efflux pump. Antimicrob Agents Chemother 2023; 67: e00358-23. https://doi.org/10.1128/aac. 00358-23 18 Baba T, Ara T, Hasegawa M et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2: 2006.0008. https://doi.org/10.1038/msb4100050 19 Thomason LC, Costantino N, Court DL. E. coli genome manipulation by P1 transduction. Curr Protoc Mol Biol 2007; 79: 1.17.1–.8. https://doi.org/ 10.1002/0471142727.mb0117s79 20 Ballestero-Téllez M, Docobo-Pérez F, Portillo-Calderón I et al. Molecular insights into fosfomycin resistance in Escherichia coli. J Antimicrob Chemother 2017; 72: 1303–9. https://doi.org/10.1093/jac/dkw573 Pérez-Palacios et al. 646 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024 21 Wirth NT, Funk J, Donati S et al. Qurve: user-friendly software for the analysis of biological growth and fluorescence data. Nat Protoc 2023; 18: 2401–3. https://doi.org/10.1038/s41596-023-00850-7 22 Deatherage DE, Barrick JE. Identification of mutations in laboratoryevolved microbes from next-generation sequencing data using Breseq. Methods Mol Biol 2014; 1151: 165–88. https://doi.org/10.1007/978-1- 4939-0554-6_12 23 Webber MA, Piddock LJ. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003; 51: 9–11. https:// doi.org/10.1093/jac/dkg050 24 Alexandre K, Chau F, Guérin F et al. Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli. J Antimicrob Chemother 2016; 71: 1899–904. https://doi.org/10.1093/jac/dkw066 25 Soubirou JF, Rossi B, Couffignal C et al. Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15. J Antimicrob Chemother 2015; 70: 1466–72. https://doi.org/10.1093/jac/dku542 26 Durão P, Balbontín R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol 2018; 26: 677–91. https://doi.org/10.1016/j.tim.2018.01.005 27 Ferrand A, Vergalli J, Pagès JM et al. An intertwined network of regulation controls membrane permeability including drug influx and efflux in Enterobacteriaceae. Microorganisms 2020; 8: 833. https://doi.org/10. 3390/microorganisms8060833 28 Verbist L. In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin. Antimicrob Agents Chemother 1982; 22: 157–61. https://doi.org/10.1128/AAC.22.1.157 29 Lartigue MF, Poirel L, Poyart C et al. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007; 13: 315–7. https://doi.org/10.3201/eid1302. 060747 30 Hu WS, Li PC, Cheng CY. Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system. Antimicrob Agents Chemother 2005; 49: 3955–8. https://doi.org/10.1128/AAC.49.9.3955-3958.2005 31 Guest RL, Raivio TL. Role of the gram-negative envelope stress response in the presence of antimicrobial agents. Trends Microbiol 2016; 24: 377–90. https://doi.org/10.1016/j.tim.2016.03.001 32 Nagakubo S, Nishino K, Hirata T et al. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC. J Bacteriol 2002; 184: 4161–7. https://doi. org/10.1128/JB.184.15.4161-4167.2002 33 Cho H, Misra R. Mutational activation of antibiotic-resistant mechanisms in the absence of major drug efflux systems of Escherichia coli. J Bacteriol 2021; 203: e0010921. https://doi.org/10.1128/JB.00109-21 34 Guerrero P, Collao B, Morales EH et al. Characterization of the BaeSR two-component system from Salmonella Typhimurium and its role in ciprofloxacin-induced mdtA expression. Arch Microbiol 2012; 194: 453–60. https://doi.org/10.1007/s00203-011-0779-5 Temocillin resistance in E. coli 647 Downloaded from https://academic.oup.com/jac/article/79/3/641/7596681 by guest on 18 October 2024